QQ客服 官方微博 反馈留言

浏览/检索结果: 共15条，第1-10条 帮助 限定条件 发表日期：2020     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 DW14383 is an irreversible pan-FGFR inhibitor that suppresses FGFR-dependent tumor growth in vitro and in vivo 期刊论文 ACTA PHARMACOLOGICA SINICA, 2020, 页码: 9 作者:  Dai, Meng-di;  Wang, Yue-liang;  Fan, Jun;  Dai, Yang;  Ji, Yin-chun 收藏  |  浏览/下载：32/0  |  提交时间：2021/05/24 receptor tyrosine kinase  FGFR inhibitor  DW14383  antitumor activity   Immune microenvironment features and efficacy of PD-1/PD-L1 blockade in non-small cell lung cancer patients with EGFR or HER2 exon 20 insertions 期刊论文 THORACIC CANCER, 2020 作者:  Chen, Kaiyan;  Pan, Guoqiang;  Cheng, Guoping;  Zhang, Fanrong;  Xu, Yanjun 收藏  |  浏览/下载：39/0  |  提交时间：2020/12/28 EGFR  HER2  immunotherapy  NSCLC  PD‐  L1   Efficacy of Pyrotinib in HER2-Overexpressing Salivary Duct Carcinoma With Lung Metastasis: A Case Report 期刊论文 FRONTIERS IN ONCOLOGY, 2020, 卷号: 10 作者:  Yang, Zi-yan;  Huang, Jia-huan;  Chen, Bo;  Xu, Chun-wei;  Lei, Lei 收藏  |  浏览/下载：26/0  |  提交时间：2020/11/30 salivary duct carcinoma  tyrosine kinase inhibitor  pyrotinib  HER2 positive  targeted   Structurally diverse halosesquiterpenoids from the red alga Laurencia composita Yamada 期刊论文 FITOTERAPIA, 2020, 卷号: 146, 页码: 9 作者:  Hu, Zhi-Biao;  Yu, Xiao-Qing;  Wang, Bin;  Liu, Ai-Hong;  Zhao, Tian-Sheng 收藏  |  浏览/下载：60/0  |  提交时间：2020/12/24 Laurencia composita  Chamigrane sesquiterpenoids  Bisabolane sesquiterpenoids  Nerolidol derivative  Modified Mosher's method  Antifungal activity  Antibacterial activity   Repurposing of Kinase Inhibitors for Treatment of COVID-19 期刊论文 PHARMACEUTICAL RESEARCH, 2020, 卷号: 37 作者:  Weisberg, Ellen;  Parent, Alexander;  Yang, Priscilla L.;  Sattler, Martin;  Liu, Qingsong 收藏  |  浏览/下载：33/0  |  提交时间：2020/10/26 Coronavirus  SARS-CoV-2  SARS-CoV  MERS-CoV  kinase inhibitors  pharmacokinetics  antiviral therapy  COVID-19   Tumor Mutation Burden Correlates With Efficacy of Chemotherapy/Targeted Therapy in Advanced Non-Small Cell Lung Cancer 期刊论文 FRONTIERS IN ONCOLOGY, 2020, 卷号: 10 作者:  Lin, Chen;  Shi, Xun;  Zhao, Jun;  He, Qiong;  Fan, Yun 收藏  |  浏览/下载：21/0  |  提交时间：2020/10/26 tumor mutation burden (TMB)  clinical benefit  epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs)  chemotherapy  non-small cell lung cancer (NSCLC)   PD-L1 expression and T cells infiltration in patients with uncommon EGFR-mutant non-small cell lung cancer and the response to immunotherapy 期刊论文 LUNG CANCER, 2020, 卷号: 142 作者:  Chen, Kaiyan;  Cheng, Guoping;  Zhang, Fanrong;  Zhu, Guanxia;  Xu, Yanjun 收藏  |  浏览/下载：24/0  |  提交时间：2020/11/26 Uncommon EGFR  Non-small cell lung cancer  PD-L1  T cell  Immunotherapy   Synthesis of triazolotriazine derivatives as c-Met inhibitors 期刊论文 MOLECULAR DIVERSITY, 2020, 页码: 8 作者:  Guo, Yuting;  Peng, Xia;  Ji, Yinchun;  Zhang, Yitong;  Ding, Jian 收藏  |  浏览/下载：37/0  |  提交时间：2020/12/24 Receptor tyrosine kinase  c-Met  Triazolotriazine  SAR  Cellular potency   Discovery and biological evaluation of N-(3-(7-((2-methoxy-4-(4-methylpiperazin-1-yl)phenyl)amino)-4-methyl-2-oxo-2H-pyrimido[4,5-d][1,3]oxazin-1(4H)-yl)phenyl)acrylamide as potent Bruton's tyrosine kinase inhibitors 期刊论文 ACTA PHARMACOLOGICA SINICA, 2020, 卷号: 41, 期号: 3, 页码: 415-422 作者:  Lai, Meng-zhen;  Song, Pei-ran;  Dou, Dou;  Diao, Yan-yan;  Tong, Lin-jiang 收藏  |  浏览/下载：34/0  |  提交时间：2020/07/01 B cell receptor  Bruton's tyrosine kinase  ibrutinib  small-molecule inhibitor  B cell malignancies   Distinct co-acquired alterations and genomic evolution during TKI treatment in non-small-cell lung cancer patients with or without acquired T790M mutation 期刊论文 ONCOGENE, 2020, 卷号: 39 作者:  Jin, Ying;  Bao, Hua;  Le, Xiuning;  Fan, Xiaojun;  Tang, Ming 收藏  |  浏览/下载：25/0  |  提交时间：2020/11/26